Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe history section gains a new Revision: v3.6.5 entry while removing the previous Revision: v3.6.4, updating the page's version-tracking metadata.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new Revision: v3.6.4 entry was added to the record history, and the prior Revision: v3.6.3 entry was removed. This updates the record's revision log to reflect the latest version.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label on the study history page updated from v3.6.2 to v3.6.3, signaling a new build of the page. The change does not alter any study details, endpoints, or results.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a small platform update and does not alter study information or navigation.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded 'No longer looking for participants', indicating enrollment has paused or ended. The history also shows Revision: v3.6.0 and removes Revision: v3.5.5 from the log.SummaryDifference0.4%

- Check65 days agoChange DetectedThe record history now shows Revision: v3.5.5, updating the metadata to reflect the latest history entry. It replaces the previous revision stamp.SummaryDifference0.1%

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.